Deferasirox
43 interactions 96 cited referencesDeferasirox is used to treat adults and children 2 years of age and older who have too much iron in their body because they received many blood transfusions. It is also used to treat adults and children 10 years of age and older who have too much iron in their body because of a genetic blood disorder called non–transfu… Read the full Deferasirox drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Deferasirox Azathioprine Azasan An increased risk of hepatotoxicity Details Deferasirox Busulfan Injection Busulfex Increased busulfan exposure Details Deferasirox Cholestyramine Resin Locholest® Decreased deferasirox concentrations Details Deferasirox Colesevelam Welchol Decreased deferasirox concentrations Details Deferasirox Colestipol Colestid Decreased deferasirox concentrations Details Deferasirox Daprodustat Jesduvroq Increased daprodustat exposure Details Deferasirox Aluminum Carbonate, Basic Decreased deferasirox effectiveness Details Deferasirox Aluminum Hydroxide AlternaGEL® Decreased deferasirox effectiveness Details Deferasirox Aluminum Oxide Decreased deferasirox effectiveness Details Deferasirox Aluminum Phosphate Decreased deferasirox effectiveness Details Deferasirox Amiodarone Nexterone Altered exposure of amiodarone Details Deferasirox Busulfan Busulfex Increased busulfan exposure Details Deferasirox Cholestyramine Prevalite Decreased deferasirox concentrations Details Deferasirox Clomipramine Anafranil Increased clomiPRAMINE exposure Details Deferasirox Dihydroxyaluminum Aminoacetate Decreased deferasirox effectiveness Details Deferasirox Dihydroxyaluminum Sodium Carbonate Decreased deferasirox effectiveness Details Deferasirox Duloxetine Increased duloxetine exposure Details Deferasirox Enzalutamide Xtandi Altered enzalutamide plasma concentrations Details Deferasirox Exagamglogene Autotemcel An increased risk of drug-drug Interactions Details Deferasirox Fosphenytoin Cerebyx Decreased deferasirox concentrations Details Deferasirox Levoketoconazole Recorlev Increased risk of serious hepatotoxicity and drug-induced liver injury Details Deferasirox Loperamide Diamode An increased loperamide exposure and an increased risk of loperamide-related adverse reactions Details Deferasirox Lovotibeglogene Autotemcel An increased risk of drug-drug Interactions Details Deferasirox Mercaptopurine Purinethol® An increased risk of hepatotoxicity Details Deferasirox Methotrexate Jylamvo Increased methotrexate exposure, an increased risk of methotrexate-related severe adverse reactions, reduced active metabolite for... Details Deferasirox Paclitaxel Abraxane Increased PACLitaxel exposure Details Deferasirox Paclitaxel Protein-Bound Increased PACLitaxel exposure Details Deferasirox Pexidartinib Turalio Hepatotoxicity Details Deferasirox Phenobarbital Fidoquel Decreased deferasirox concentrations Details Deferasirox Phenytoin Dilantin Decreased deferasirox concentrations Details Deferasirox Pimozide Increased pimozide exposure and an increased risk of pimozide-related adverse reactions Details Deferasirox Resmetirom Rezdiffra Increased resmetirom exposure and an increased risk of resmetirom-related adverse reactions Details Deferasirox Rifampin Rifadin Decreased deferasirox concentrations Details Deferasirox Ritonavir Norvir Decreased deferasirox concentrations Details Deferasirox Selexipag Uptravi Increased exposure of selexipag and its active metabolite Details Deferasirox Theophylline Accurbron® Increased theophylline concentrations Details Deferasirox Tizanidine Increased tiZANidine exposure, an increased risk of tiZANidine-related hypotension, bradycardia or increased drowsiness Details Deferasirox Tovorafenib Ojemda Increased tovorafenib exposure and an increased risk of tovorafenib-related adverse effects Details Deferasirox Tucatinib Tukysa Increased tucatinib exposure and risk of toxicity Details Deferasirox Warfarin Coumadin Increased warfarin exposure DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist